Tadasiva: Advanced Erectile Dysfunction Therapy with Sustained Efficacy
Tadasiva
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 36 | $1.31 | $47.00 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $78.33 $66.00 (16%) | 🛒 Add to cart |
| 84 | $0.90
Best per pill | $109.67 $76.00 (31%) | 🛒 Add to cart |
Tadasiva represents a significant advancement in the pharmacological management of erectile dysfunction (ED), offering a reliable and well-tolerated treatment option for adult males. This medication contains Tadalafil, a potent phosphodiesterase type 5 (PDE5) inhibitor that facilitates increased blood flow to the penile tissues upon sexual stimulation. Its unique pharmacokinetic profile allows for a prolonged therapeutic window, providing patients with greater spontaneity and reduced anxiety associated with timed dosing. Clinical studies and extensive post-market surveillance confirm its high efficacy rate and favorable safety profile, making it a cornerstone therapy in modern urological practice.
Features
- Active Pharmaceutical Ingredient: Tadalafil 5mg, 10mg, 20mg film-coated tablets.
- Mechanism of Action: Selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).
- Pharmacokinetics: Rapid absorption with a median time to maximum plasma concentration (Tmax) of 2 hours; terminal half-life of approximately 17.5 hours.
- Excretion: Primarily metabolized by the liver via CYP3A4 and excreted predominantly as metabolites in the feces (~61%) and urine (~36%).
- Presentation: Almond-shaped tablets, debossed with strength identification.
Benefits
- Achieves and maintains erections sufficient for satisfactory sexual activity with a high degree of reliability.
- Provides an extended period of responsiveness (up to 36 hours), reducing the pressure of scheduling intimacy and enabling greater spontaneity.
- Improves overall sexual confidence and reduces performance-related anxiety, contributing to better psychological well-being.
- Effective in treating ED associated with a variety of underlying conditions, including diabetes mellitus and post-prostatectomy cases.
- A simple, once-daily low-dose regimen is available for men anticipating frequent sexual activity, ensuring consistent therapeutic levels.
- Demonstrated improvement in erectile function domain scores on validated instruments like the International Index of Erectile Function (IIEF).
Common use
Tadasiva is primarily indicated for the treatment of erectile dysfunction, the consistent or recurrent inability to attain and/or maintain a penile erection sufficient for satisfactory sexual performance. It is also approved for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It may be used in patients with ED of various etiologies, including vasculogenic, neurogenic, and psychogenic origins, as well as mixed etiologies. It is not indicated for use in women or children.
Dosage and direction
For as-needed treatment of erectile dysfunction, the recommended starting dose is 10 mg, taken orally at least 30 minutes prior to anticipated sexual activity. The dose may be increased to 20 mg or decreased to 5 mg based on efficacy and tolerability. Dosing should be limited to a maximum of one dose per 24-hour period. For daily use, the recommended dose is 2.5 mg, taken orally at approximately the same time each day, without regard to the timing of sexual activity. The daily dose may be increased to 5 mg based on individual efficacy and tolerability. Tadasiva may be taken with or without food. The tablet should be swallowed whole with a glass of water; it should not be split, crushed, or chewed.
Precautions
Prior to prescribing Tadasiva, physicians should conduct a thorough medical and sexual history assessment to determine the underlying etiology of ED and identify appropriate treatment candidates. Patients with cardiovascular disease should be evaluated for their suitability for sexual activity, as it involves a certain degree of cardiac exertion. Use with caution in patients with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, or Peyronie’s disease) or conditions that may predispose them to priapism (e.g., sickle cell anemia, multiple myeloma, or leukemia). Patients should be advised that Tadasiva offers no protection against sexually transmitted diseases. Prolonged erections lasting more than 4 hours require immediate medical attention to prevent long-term tissue damage.
Contraindications
Tadasiva is strictly contraindicated in all patients who are using any form of organic nitrates or nitric oxide donors (e.g., amyl nitrite “poppers”), either regularly or intermittently, due to the risk of a precipitous and potentially fatal drop in blood pressure. It is also contraindicated in patients with a known hypersensitivity to Tadalafil or any of the tablet’s excipients. Concomitant use with guanylate cyclase stimulators, such as riociguat, is contraindicated. Its use is not recommended in patients with severe hepatic impairment (Child-Pugh Class C) or severe uncontrolled hypertension.
Possible side effect
The most commonly reported adverse reactions are headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and limb pain. These are typically transient and mild to moderate in severity. Back pain and myalgia are often described as a deep muscular discomfort and usually resolve within 48 hours. Less common side effects include dizziness, visual disturbances (non-arteritic anterior ischemic optic neuropathy has been reported rarely), tinnitus, and palpitations. Priapism (a painful erection lasting more than 4 hours) is a rare but serious adverse event requiring urgent medical intervention.
Drug interaction
Concomitant administration with nitrates is absolutely contraindicated. Potent inhibitors of the cytochrome P450 3A4 (CYP3A4) isoenzyme (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin) can increase Tadalafil exposure; a dose reduction is recommended. Concomitant use with alpha-adrenergic blockers (e.g., doxazosin) can potentially lead to symptomatic hypotension; such combination therapy should be initiated only if the patient is stable on their alpha-blocker therapy. Tadasiva may potentiate the hypotensive effects of antihypertensive medications. Alcohol can potentiate both the blood-pressure-lowering effects and orthostatic signs and symptoms.
Missed dose
For the as-needed dosing regimen: This regimen is not dependent on a daily schedule. If a dose is missed, it is not to be replaced; the next dose should be taken at least 24 hours before the next anticipated sexual activity. For the once-daily dosing regimen: If a dose is missed, the patient should take it as soon as remembered. If it is almost time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. The patient should not take a double dose to make up for the missed one.
Overdose
In cases of suspected overdose, standard supportive measures should be employed. The primary expected hemodynamic effect is hypotension. Cardiovascular status should be monitored and appropriate management for hypotension instituted, which may include fluid resuscitation and, if necessary, vasopressor agents. Hemodialysis is not expected to accelerate clearance as Tadalafil is highly bound to plasma proteins and not significantly eliminated in the urine.
Storage
Store at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the medication in its original blister pack or container to protect it from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read in this product description.
Reviews
“After trying another medication with a much shorter window of effectiveness, my urologist recommended switching to Tadasiva. The 36-hour flexibility has been a game-changer for my relationship, removing the ‘countdown clock’ and associated anxiety. The effect is reliable and has significantly improved my quality of life.” – M.C., 58
“As a primary care physician, I find Tadasiva to be an invaluable tool in my practice. The once-daily option is particularly beneficial for my patients in stable relationships who desire spontaneity. The side effect profile is generally well-tolerated, and patient satisfaction scores are consistently high. It’s a well-researched and dependable choice.” – Dr. A. Sharma, MD
“I was initially hesitant to seek treatment for ED. My doctor patiently explained the mechanism and started me on the lowest dose. The effect was noticeable and, importantly, felt very natural. I experienced some minor flushing the first time, but it did not recur. I appreciate the discretion and effectiveness this treatment offers.” – J.L., 49